Ian also had the courage to do a Proactive interview this...

First 17 Last

Share
Profile

Follow
RoyE

1,857 Posts.

1003

14/03/24

18:42

Post #: 72892193
Share

Originally posted by Aqua65: ↑

This is an amazing buying opportunity.

Did an insto dump? New entrants perhaps from the CR.
Then a cascade of selling, recent buyers fueled ?

Our CPM Ceo is simply honest and trustworthy.
He is heavily personally invested also- and at way above this shareprice.
In any case Ian is a solid Geo and has reported on this at once —instead of holding it until the drill campaign completion, as maybe not the anticipated drill results, for this hole especially.

The Brumby Ridge drilling is actually ongoing still right now, for additional perspective.
He will organise new drill holes at pivoted (angled) orientation to determine why the aberrance to the fantastic drill results from end of 2023 for this location Brumby Ridge.

Cooper is well- funded for this year with over $5 million in the bank.

Brumby Ridge alone is an extensive area, with ongoing drilling to occur.
The company holds though considerable highly prospective territory at Cloncurry-Isa, with other tenements with previous resource discovery success, & great overall area held.

Drilling is actually to be ongoing and through this year, and onwards.

So this is crazy - an EV of $5 million only?

Expand

Ian also had the courage to do a Proactive interview this morning to clarify the current status which I thought was good, Rather than ignore the disgruntled shareholders and try to keep a low profile, he has proactively addressed the issue, which IMO is the right thing to do and reflects well on Ian's integrity and respect for shareholders.

GLTA & DYOR

CPM Price at posting: 14.0¢ Sentiment: Buy Disclosure: Held
13 Upvote

1 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 10 more messages in this thread...

First 17 Last

Add CPM (ASX) to my watchlist

(20min delay)
Last 5.4¢		Change -0.004(6.90%)		Mkt cap ! $4.231M

Open	High	Low	Value	Volume
5.4¢	5.4¢	5.4¢	$1.544K	28.60K

Buyers (Bids)

No.	Vol.	Price($)
2	79134	5.2¢

Sellers (Offers)

Price($)	Vol.	No.
5.8¢	176801	2

View Market Depth

No.	Vol.	Price($)
2	79134	0.052
1	120000	0.051
1	400	0.050
1	10000	0.049
1	10377	0.047

Price($)	Vol.	No.
0.058	176801	2
0.059	50000	1
0.062	50000	1
0.065	30000	1
0.068	21999	1

Last trade - 15.32pm 07/10/2024 (20 minute delay)

CPM (ASX) Chart

Ian also had the courage to do a Proactive interview this...

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ian also had the courage to do a Proactive interview this...

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News